Notice of Pre-AIA or AIA Status
The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Continued Examination Under 37 CFR 1.114
A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on July 20, 2026 has been entered.
Claim Rejections - 35 USC § 103
The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action:
A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made.
Claims 1-5 are rejected under 35 U.S.C. 103 as being unpatentable over Yamazaki et al., WO 2022/004464 for the reasons outlined previously. Rejection of claims 6-10 is justified for the reasons that follow.
Claim 6 sets a new lower limit defining the mass contribution of component (D). By the Examiner’s calculation, prior art Embodiment 6 (the focus of the last Office communication) has an amount of the prior art organohydrogensiloxane, c1-2, correlated with claimed component (D) of 11.1%. While the Examiner acknowledges that that this figure is outside of the currently claimed range, it is submitted that it is sufficiently close in magnitude that a skilled practitioner of the prior art invention has a reasonable expectation that it will be in possession of approximately the same properties as an analogous composition differing only in that the amount of c1-2 is 13% by weight. “A prima facie case of obviousness exists where the claimed ranges and prior art ranges do not overlap but are close enough that one skilled in the art would have expected [the claimed product and a product disclosed in the prior art] to have the same properties.” Titanium Metals Corp. of America v. Banner, 778 F.2d 775, 227 USPQ 773 (Fed. Cir. 1985).
It is further noted that the experimental data provided by the Specification is not designed to establish 13 mass% of (D) as critical to the practice of the instant invention. Indeed, how could it be when claim allows that the weight contribution of (D) is as low as 5%? Several of the comparative examples contain none of component (D) whatsoever and at least one other contains no (C). Only one comparative example comprises both of (C) and (D) and it deviates from the claimed invention by containing more of the latter than had been contemplated by the original disclosure.
Claims 7-10 further limit claim 6 in the same manner as claims 2-5 limit claim 1.
Response to Arguments
Applicant’s assertion of patentability over Yamazaki hinges on the notion that the reference requires the presence of a non-reactive silicone resin whereas the claims now demand its absence. The Examiner, however, respectfully disagrees that component (A2) is non-reactive (a concept that is not-at-all developed within the Specification). Instead, what the reference says is that (A2) does not contain a curing reactive functional group in the form of a carbon-carbon double bond [0044]. What it does contain though is up to 5 mol% of silicon bound hydroxyl- or alkoxy groups. See [0045] and [0047].
It seems that Applicant may have intended that the non-reactive silicone resin [0058] representing one permutation of the organic filler of [0053] is one that won’t participate in the reaction by which the instant composition is cured. Because Applicant doesn’t address the meaning of “non-reactive”, it is appropriate for the Examiner to apply a broadest reasonable interpretation standard that assigns to “non-reactive silicone resin” the condition that it be entirely devoid of any groups that may participate in a reaction of some kind. Certainly, it can be said that the silicon-bound hydroxyl/alkoxy groups are reactive and thus prior art (A2) is, in contrast to what Applicant asserts, not a non-reactive silicone resin.
U.S. Patent Application Publication No. 2007/0106016 is cited as being of interest but not especially germane to the patentability of the instant claims for, while Table 2 summarizes the makeup of compositions that contain all of claimed components (A) to (E), they are added in much different proportions.
Any inquiry concerning this communication or earlier communications from the examiner should be directed to MARC S ZIMMER whose telephone number is (571)272-1096. The examiner can normally be reached M-F 8:30-5:00.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Heidi Kelley can be reached at 571-270-1831. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
August 13, 2026
/MARC S ZIMMER/Primary Patent Examiner, Art Unit 1765